Hideki Kanda

1.4k total citations
73 papers, 693 citations indexed

About

Hideki Kanda is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Strategy and Management. According to data from OpenAlex, Hideki Kanda has authored 73 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 8 papers in Strategy and Management. Recurrent topics in Hideki Kanda's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Urological Disorders and Treatments (7 papers). Hideki Kanda is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Urological Disorders and Treatments (7 papers). Hideki Kanda collaborates with scholars based in Japan, United States and Germany. Hideki Kanda's co-authors include Kiminobu Arima, Yoshiki Sugimura, Kenichiro Ishii, Curtis J. Milhaupt, Takeshi Sasaki, Manabu Kato, Masahiro Kanai, Yuji Ogura, Klaus J. Hopt and Yoichi Iwamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.

In The Last Decade

Hideki Kanda

68 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideki Kanda Japan	15	214	169	140	114	88	73	693
Michael G. Martin United States	16	140 0.7×	177 1.0×	126 0.9×	294 2.6×	41 0.5×	69	865
Qianyi Sun China	7	123 0.6×	145 0.9×	40 0.3×	36 0.3×	57 0.6×	15	455
Xiaoqian Zhang China	14	39 0.2×	163 1.0×	125 0.9×	83 0.7×	60 0.7×	19	515
Daniel J. Kelley United States	16	89 0.4×	181 1.1×	34 0.2×	241 2.1×	69 0.8×	24	887
Eunho Cho United States	15	31 0.1×	207 1.2×	151 1.1×	78 0.7×	147 1.7×	40	615
Howard Chan Australia	16	52 0.2×	192 1.1×	254 1.8×	97 0.9×	84 1.0×	30	742
Young-Kyu Park South Korea	11	292 1.4×	57 0.3×	199 1.4×	60 0.5×	222 2.5×	36	773
Hideki Konishi Japan	18	87 0.4×	96 0.6×	31 0.2×	75 0.7×	14 0.2×	38	596
Rui Zhao China	18	53 0.2×	189 1.1×	367 2.6×	74 0.6×	77 0.9×	84	1.6k
Isabelle Royer France	13	408 1.9×	124 0.7×	22 0.2×	203 1.8×	84 1.0×	34	985

Countries citing papers authored by Hideki Kanda

Since Specialization

Citations

This map shows the geographic impact of Hideki Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Kanda more than expected).

Fields of papers citing papers by Hideki Kanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Kanda. The network helps show where Hideki Kanda may publish in the future.

Co-authorship network of co-authors of Hideki Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Kanda. A scholar is included among the top collaborators of Hideki Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Kanda. Hideki Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sasaki, Takeshi, Toshifumi Takahashi, Hideki Kanda, et al.. (2023). Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer Patients. Clinical Genitourinary Cancer. 21(6). e474–e484. 1 indexed citations

Kanda, Hideki, et al.. (2023). Targeted Antimicrobial Prophylaxis with Cefmetazole Based on Presence of Fluoroquinolone-Resistant Isolates to Prevent Post-Prostate Biopsy Infectious Complications. SHILAP Revista de lepidopterología. 3(2). 168–176.

Sasaki, Takeshi, Manabu Kato, Takashi Okamoto, et al.. (2021). Prognostic Effect of Preoperative Psoas Muscle Hounsfield Unit at Radical Cystectomy for Bladder Cancer. Cancers. 13(22). 5629–5629. 4 indexed citations

Ishihara, Mikiya, Yoshihiro Miyahara, Daisuke Muraoka, et al.. (2020). First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors. Cancer Immunology Immunotherapy. 69(4). 663–675. 21 indexed citations

Ishii, Kenichiro, Takeshi Sasaki, Manabu Kato, et al.. (2019). Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure. Laboratory Investigation. 100(5). 670–681. 8 indexed citations

Fleischer, Holger, et al.. (2017). German and Asian Perspectives on Company Law. Mohr Siebeck eBooks. 1 indexed citations

Kanda, Hideki. (2015). Corporate Governance in Japanese Law: Recent Trends and Issues. 11(1). 69. 1 indexed citations

Sasaki, Takeshi, Kenichiro Ishii, Yoichi Iwamoto, et al.. (2015). Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer. Laboratory Investigation. 96(3). 338–349. 15 indexed citations

Mizuno, Shugo, Hideki Kanda, Yohei Yamada, et al.. (2014). Usefulness of Monitoring Cell-Mediated Immunity for Predicting Post–Kidney Transplantation Viral Infection. Transplantation Proceedings. 46(2). 552–555. 6 indexed citations

10.

Kraakman, Reinier, John Armour, Paul Davies, et al.. (2009). The Anatomy of Corporate Law: A Comparative and Functional Approach. CBS Research Portal (Copenhagen Business School). 99 indexed citations

11.

Kanda, Hideki, Kenichiro Ishii, Yuji Ogura, et al.. (2007). Naftopidil, a selective α‐1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest. International Journal of Cancer. 122(2). 444–451. 55 indexed citations

12.

Jackson, Howell E., Hideki Kanda, Joon‐Ho Hahm, et al.. (2006). Regulatory Reforms in the Age of Financial Consolidation: The Emerging Market Economy and Advanced Countries. 2 indexed citations

13.

Kanda, Hideki. (1999). Comparative Corporate Governance Country Report: Japan. SSRN Electronic Journal. 8 indexed citations

14.

Kanda, Hideki. (1998). Securitization In Japan. Duke journal of comparative & international law. 8(2). 359–380. 2 indexed citations

15.

Kanda, Hideki. (1997). Globalization of Financial Markets and Financial Regulation in Japan. 2(4). 9–17. 1 indexed citations

16.

Kanda, Hideki. (1996). Taxes and the Structure of Japanese Firms: The Hidden Aspects of Income Taxation. Open Scholarship Institutional Repository (Washington University in St. Louis). 74(2). 393–418. 1 indexed citations

17.

Kanda, Hideki. (1995). Developments in Japanese Securities Regulation: An Overview. SMU Scholar (Southern Methodist University). 29(3). 599. 1 indexed citations

18.

Kanda, Hideki. (1991). Politics, Formalism, and the Elusive Goal of Investor Protection: Regulation of Structured Investment Funds in Japan. University of Pennsylvania journal of international economic law. 12(4). 569. 4 indexed citations

19.

Macey, Jonathan R. & Hideki Kanda. (1990). The Stock Exchange as a Firm: The Emergence of Close Substitutes for the New York and Tokyo Stock Exchanges. Cornell law review/The Cornell law quarterly. 75(5). 1006–1051. 15 indexed citations

20.

Levmore, Saul & Hideki Kanda. (1985). The Appraisal Remedy and the Goals of Corporate Law. UCLA law review. 32. 429. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact